Interaction of D2-dopamine receptor with two pertussis toxin sensitive G proteins in human placenta.
We have demonstrated the presence in human placenta of D2 dopamine receptors (D2R) which inhibit human placental lactogen (hPL) release. This inhibitory effect of dopamine (DA) was sensitive to pertussis toxin (PTX) indicating that it may be mediated by the Gi/Go family of G proteins. However, nothing is known on this G proteins/D2R interaction in human placenta. In this study, we demonstrate that DA (10(-4) M) inhibits by 39% the ADP-ribosylation by PTX of two G proteins of 40 and 41 kDa. This inhibition is receptor specific since it is reversed by spiperone, a D2R antagonist. Moreover we show that bromocriptine, a D2 agonist, inhibited the labeling of these two proteins in a dose-dependent manner with a maximal inhibition of 37% at a concentration of 10(-6) M. In order to understand the role of D2R in placental endocrinology, we have analyzed the interactions of these two PTX-sensitive G proteins with D2R in normal and abnormal pregnancies. The autoradiographs of both PTX ADP-ribosylated placental proteins of 40 and 41 kDa showed differential labeling during normal pregnancy. Thus, the relative levels of ADP-ribosylation by PTX of both proteins were 2.5 and 3.0 fold lower at term than those observed during first and second trimester whereas no difference was observed between the first and second trimester. Also, no significant change in the level of inhibition by DA was observed between 7-9 weeks and 18-40 weeks of pregnancies (35-45% inhibition). However, we observed a maximal inhibition between 10 to 17 weeks of pregnancy (64% inhibition). In placentas from preeclamptic pregnancies, the levels of ADP-ribosylation were similar to those observed in normal pregnancy, while the DA inhibition was increased by 24%. The levels of ADP-ribosylation in molar placentas reached 20% of normal values, while no difference in DA inhibition was observed. This study demonstrates that two distinct PTX-sensitive G proteins are coupled to human placental D2R. The physiological significance of the variations in these ADP-ribosylated-G proteins/D2R interaction during normal and preeclamptic pregnancies remains to be investigated.
Vaillancourt
C
C
Department of Obstetrics and Gynecology, University of Montreal, Ste-Justine Hospital, Quebec, Canada.
Petit
A
A
Bélisle
S
S
D000244:Adenosine Diphosphate / Q000378:metabolism; D004298:Dopamine / Q000494:pharmacology; D005260:Female; D019204:GTP-Binding Proteins / Q000378:metabolism*; D006801:Humans; D006828:Hydatidiform Mole / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism; D037342:Pertussis Toxin; D010920:Placenta / Q000378:metabolism* / Q000648:ultrastructure*; D011225:Pre-Eclampsia / Q000378:metabolism; D011247:Pregnancy; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D012266:Ribose / Q000378:metabolism; D012680:Sensitivity and Specificity; D014327:Trophoblasts / Q000378:metabolism; D014594:Uterine Neoplasms / Q000378:metabolism; D010566:Virulence Factors, Bordetella / Q000494:pharmacology*
D008565:Membrane Proteins; D017448:Receptors, Dopamine D2; D010566:Virulence Factors, Bordetella; D000244:Adenosine Diphosphate; D012266:Ribose; D037342:Pertussis Toxin; D019204:GTP-Binding Proteins; D004298:Dopamine